Drug Common Name Schedule Date of DPH Schedule Orders Code Section
N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-l H-benzimidazol-1-yl)ethan-1-amine N¬desethyl isotonitazene C-I 8/28/2024 Order 44-53-190
2-(4-ethoxybenzyl)-5-nitro-1-{2-(piperidin-1-yl)ethyl}-lH -benzimidazole N¬piperidinyl etonitazene or etonitazepipne C-I 8/28/2024 Order 44-53-190
1-(2-methyl-4-4(3- phenylprop-2-en-l-yl)piperazin-1-yl)butan-1-one 2-methyl AP-237 C-I 4/11/2024 Board Order 44-53-190
Methyl 2-(1-(4-fluorobenzyl)-lH-indole-3- carboxamido)-3-methyl butanoate MMB-FUBICA C-I 01/04/2024 Board Order 44-53-190
Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino ]-3,3-dimethyl-butanoate 5F-EDMB-PICA C-I 01/04/2024 Board Order 44-53-190
5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[ 4,3-b ]indol-1-one CUMYL-­PEGACLONE C-I 01/04/2024 Board Order 44-53-190
-(l­amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-l-yl)-lH-indazole-3-carboxamide ADB- 4en-PINACA C-I 01/04/2024 Board Order 44-53-190
Methyl 2-[[1-( 4-fluorobutyl)indole-3- carbonyl]amino]-3,3-dimethyl-butanoate 4F-MDMB-BUTICA C-I 01/04/2024 Board Order 44-53-190
Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-lH-indazole-3- carboxamido )butanoate MDMB-4en-PINACA C-I 01/04/2024 Board Order 44-53-190
N-(3-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)propionamide Meta­-fluorofentanyl C-I 01/04/2024 Board Order 44-53-190
N-(3-fluorophenyl)-N-( l­phenethylpiperidin-4-yl)isobutyramide  Meta-fluoroisobutyryl fentanyl C-I 01/04/2024 Board Order 44-53-190
N-(4-methoxyphenyl)-N-(l­phenethylpiperidin-4-yl)furan-2-carboxamide  Para-methoxyfuranyl fentanyl C-I 01/04/2024 Board Order 44-53-190
N-(l-phenethylpiperidin-4-yl)-N­phenylfuran-3-carboxamide ) 3-furanyl fentanyl C-I 01/04/2024 Board Order 44-53-190
N-( 1-(2,5-dimethoxyphenethy l)piperidin-4-y 1)-N­phenylpropionamide  2 ',5 '-dimethoxyfentanyl  C-I 01/04/2024 Board Order 44-53-190
3-methyl-N-(l-phenethylpiperidin-4-yl)-N-phenylbutanamide Isovaleryl fentanyl C-I 01/04/2024 Board Order 44-53-190
N-(2-fluorophenyl)-N-(l -phenethylpiperidin-4-y l)furan-2-carboxamide  Ortho-fluorofuranyl fentanyl C-I 01/04/2024 Board Order 44-53-190
2-methyl-N-( l-phenethylpiperidin-4-yl)-N-phenylbutanamide  Alpha'-methyl butyryl fentanyl C-I 01/04/2024 Board Order 44-53-190
N-( 4-methylphenyl)-N-(l-phenethylpiperidin-4- yl)cyclopropanecarboxamide Para-­methylcyclopropyl fentanyl C-I 01/04/2024 Board Order 44-53-190
 1- [2-[(3R,5R,8R,9R,10S,13S,14S,17S)-3- hydroxy-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17- tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2- oxoethyl]pyrazole-4-carbonitrile Zuranolone C-IV 11/9/2023 Board Order 44-53-250
7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2Hbenzo[e][1,4]diazepin-2-one Diclazepam C-I 08/10/2023 Board Order 44-53-190
8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-1][1,4]diazepine (alternate chemical name: 8-bromo-6-(2-flurophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine Flubromazolam C-I 08/10/2023 Board Order 44-53-190
6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-1][1,4]diazepine Clonazolam C-I 08/10/2023 Board Order 44-53-190
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine Flualprazolam C-I 08/10/2023 Board Order 44-53-190
4-(2-chlorophenyl-2-ethyl-9- methyl-6H-thieno[3,2-f][1, 2, 4] triazolo[4,3-a][1,4]diazepine Etizolam C-I 08/10/2023 Board Order 44-53-190
N-ethyl-α-methyl-3-(trifluoromethyl)phenethylamine Fenfluramine C-IV 01/05/2023 Board Order 43-53-250
N-methyl-1-(thiophen-2-yl)propan-2-amine Methiopropamine C-I 01/05/2023 Board Order 44-53-190
N-phenyl-N' -(3-(1 - phenylpropan-2-yl)-1, 2, 3-oxadiazol-3- ium-5-yl) carbamimidate) Mesocarb C-I 12/08/2022 Board Order 44-53-190
7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) Amineptine C-I 12/08/2022 Board Order 44-53-190
1-methoxy-3-[4-(2- methoxy-2-phenylethyl)piperazin-1-yl]- 1-phenylpropan-2-ol) Zipeprol C-I 12/08/2022 Board Order 44-53-190
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one Methoxetamine C-I 06/29/2022 Board Order 44-53-190
[(3􀄮-hydroxy-3􀈕-methyl-5􀄮-pregnan-20-one) Ganaxolone C-V 06/29/2022 Board Order 44-53-270
N,N-diethyl-2-(5-nitro-2-( 4-propoxybenzyl)-lH-benzimidazol-l-yl)ethan-1- amine Protonitazene C-I 05/05/2022 Board Order 44-53-190(B)
2-( 4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-lH-benzimidazole N-Pyrrolidino etonitazene C-I 05/05/2022 Board Order 44-53-190(B)

N,N-diethyl-2-(2-( 4-methoxybenzyl)-5-nitro-lH-benzimidazol-1-yl)ethan-l- amine

Metonitazene

 C-I 05/05/2022 Board Order 44-53-190(B)
N,N-diethyl-2-(2-(4-methoxybenzyl)-lH­benzimidazol-1-yl)ethan-1-amine Metodesnitazene C-I 05/05/2022 Board Order 44-53-190(B)

N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-lH-benzimidazol-1-yl)ethan-1- amine

 Flunitazene C-I 05/05/2022 Board Order 44-53-190(B)

2-(2-( 4-ethoxybenzyl)-lH-benzimidazol-1-yl)-N,N-diethylethan-1-amine

 Etodesnitazene C-I 05/05/2022 Board Order 44-53-190(B)
2-(2-(4-butoxybenzyl)-5-nitro-IH-benzimidazol-l-yl)-N,N­diethylethan-l- amine

Butonitazene

 C-I 05/05/2022 Board Order 44-53-190(B)
4,4′-Dimethylaminorex; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4- methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine 4,4′-DMAR C-I 09/09/2021 Board Order 44-53-190(F)

1-(4- methoxyphenyl)-N-methylpropan-2- amine (paramethoxymethamphetamine)

para-Methoxymethamphetamine (PMMA)

C-I

07/15/2021

 Board Order

44-53-190(D)

methyl 2-(1- (4-fluorobutyl)-1H-indazole-3- carboxamido)-3,3-dimethylbutanoate

4F–MDMB–BUTINACA

C-I

07/15/2021

 Board Order

44-53-190(D)
3-[[[(1S)-1-carboxy-2-hydroxyethyl]- amino]carbonyl]-1-[[[[(2R)-2-[(1R)-2-methoxy-2-oxo-1-phenylethyl]-1- piperidinyl]carbonyl]oxy]methyl]pyridinium chloride Serdexmethylphenidate C-IV 05/13/2021 Board Order 44-53-250
Ethyl (1-phenethylpiperidin-4- yl)(phenyl)carbamate (fentanyl carbamate) Fentanyl Carbamate C-1 05/13/2021 Board Order 44-53-190(B)
N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)acrylamide (ortho-fluoroacryl fentanyl) Ortho-fluoroacryl Fentanyl C-1 05/13/2021 Board Order 44-53-190(B)
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (ortho-fluoroisobutyryl fentanyl) Ortho-fluoro Isobutyryl Fentanyl C-1 05/13/2021 Board Order 44-53-190(B)
N-(4-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)furan-2-carboxamide (para-fluoro furanyl fentanyl) Para-fluoro Furanyl Fentanyl C-1 05/13/2021 Board Order 44-53-190(B)

N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide
(2′-fluoro ortho-fluorofentanyl; 2′-fluoro 2-fluorofentanyl

 2′-Fluoro Ortho-fluorofentanyl C-1 05/13/2021 Board Order 44-53-190(B)
N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide (4′-methyl acetyl fentanyl) 4′- methyl acetyl fentanyl C-I 05/13/2021 Board Order 44-53-190(B)
N-phenyl-N-(1-(2- phenylpropyl)piperidin-4- yl)propionamide (b-methyl fentanyl) b-methyl fentanyl C-I 05/13/2021 Board Order 44-53-190(B)
N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)butyramide (ortho-fluorobutyryl fentanyl; 2-fluorobutyryl fentanyl) orthofluorobutyryl fentanyl C-I 05/13/2021 Board Order 44-53-190(B)
N-(2-methylphenyl)-N-(1- phenethylpiperidin-4-yl)acetamide (ortho-methyl acetylfentanyl; 2-methyl acetylfentanyl) ortho-methyl acetylfentanyl C-I 05/13/2021 Board Order 44-53-190(B)
2-methoxy-N-(2-methylphenyl)-N- (1-phenethylpiperidin-4-yl)acetamide (ortho-methylmethoxyacetylfentanyl; 2-methyl methoxyacetyl fentanyl) Ortho-methyl Methoxyacetyl Fentanyl C-I 05/13/2021 Board Order 44-53-190(B)
N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (para-methylfentanyl; 4- methylfentanyl) Paramethyl Fentanyl C-I 05/13/2021 Board Order 44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide (phenyl fentanyl; benzoyl fentanyl) Phenyl Fentanyl C-I 05/13/2021 Board Order 44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide (thiofuranyl fentanyl; 2-thiofuranyl fentanyl; thiophene fentanyl) Thiofuranyl Fentanyl C-I 05/13/2021 Board Order 44-53-190(B)
Oliceridine N-[(3- methoxythiophen-2-yl)methyl] ({2- [(9R)-9-(pyridin-2-yl)-6- oxaspiro [4.5]decan-9-yl]ethyl})amine fumarate Oliceridine C-II 11/12/2020 Board Order 44-53-210
Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) Crotonyl Fentanyl  C-I 10/08/2020 Board Order 44-53-190(B)
Remimazolam (4H-imidazol[1,2-a][1,4]benzodiazepine-4-propionic acid, 8-bromo-1-methyl-6-(2-pyridinyl)-(4S)- methyl ester, benzenesulfonate (1:1) or methyl 3-[(4S)-8-bromo-1-methyl-6- pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin-4yl]propanoate benzenesulfonic acid) Remimazolam C-IV 10/08/2020 Board Order 44-53-250(A)
N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)ethan-1-amine, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other names: isotonitazene; N,N-diethyl-2-[[4- (1-methylethoxy)phenyl]methyl]- 5-nitro-1H-benzimidazole-1- ethanamine) Isotonitazene C-I 9/10/2020 Board Order 44-53-190(B)
N-phenyl-N- (piperidin-4-yl)propionamide (norfentanyl)   Norfentanyl C-II 5/7/2020 Board Order 45-53-210
Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)    Cenobamate C-V 4/9/2020 Board Order 44-53-270
Lemborexant (1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5- fluoropyridin-2-yl)cyclopropane-1-carboxamide Lemborexant C-IV 4/9/2020 Board Order 44-53-250
Lasmiditan (2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide) and its salts, isomers, and salts of isomers. Lasmiditan C-V 2/13/2020 Board Order 44-53-270
N-Ethylhexedrone, its optical, positional, and geometric isomers, salts and salts of isomers (Other name: 2-(ethylamino)-1-phenylhexan-1-one) N-Ethylhexedrone C-I 8/8/2019 Board Order 44-53-190(F)
alpha-Pyrrolidinohexanophenone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: α-PHP; alpha-pyrrolidinohexiophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one) α-PHP C-I 8/8/2019 Board Order 44-53-190(F)
4-Methyl-alpha-ethylaminopentiophenone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: 4–MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one) 4-MEAP C-I 8/8/2019 Board Order 44-53-190(F)
4′-Methyl-alpha-pyrrolidinohexiophenone, its optical, positional, and geometric isomers, salts and salts of isomers  (Other names: MPHP; 4′-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one) MPHP C-I 8/8/2019 Board Order 44-53-190(F)
alpha-Pyrrolidinoheptaphenone, its optical, positional, and geometric isomers, salts and salts of isomers  (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one) PV8 C-I 8/8/2019 Board Order 44-53-190(F)
4′-Chloro-alpha-pyrrolidinovalerophenone, its optical, positional, and geometric isomers, salts and salts of isomers  (Other names: 4-chloro-α-PVP; 4′-chloro-alpha-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one) 4-Chloro-α-PVP C-I 8/8/2019 Board Order 44-53-190(F)
Solriamfetol (2-amino-3-phenylpropyl car-bamate; benzenepropanol, beta-amino-, carbamate (ester)) Solriamfetol C-IV 7/11/2019 Board Order 44-53-250(b)
Brexanolone Brexanolone C-IV 7/11/2019 Board Order 44-53-250(a)
ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, its optical, positional, and geometric isomers, salts and salts of isomers 5F-EDMB-PINACA C-I 5/9/2019 Board Order 44-53-190(D)
methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate, its optical, positional, and geometric isomers, salts and salts of isomers 5F-MDMB-PICA C-I 5/9/2019 Board Order 44-53-190(D)
N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL) C-I 5/9/2019 Board Order 44-53-190(D)
1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers 5F-CUMYL-PINACA; SGT-25 C-I 5/9/2019 Board Order 44-53-190(D)
(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone, its optical, positional, and geometric isomers, salts and salts of isomers FUB-144 C-I 5/9/2019 Board Order 44-53-190(D)
N-Ethylpentylone, its optical, positional, and geometric isomers, salts and salts of isomers ephylone,  N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone C-I 9/27/2018 Board Order 44-53-190(F)(4)
Naphthalen-1-yl 1-(5-fluoropentyl)-1 H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts and salts of isomers NM2201; CBL2201 C-I 7/12/2018 Board Order
44-53-190(D)
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1 H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers 5F-AB-PINACA C-I 7/12/2018 Board Order
44-53-190(D)
1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1 H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78 C-I 7/12/2018 Board Order
44-53-190(D)
methyl 2-(1-(cyclohexylmethyl)-1 H-indole-3-carboxamido)-3-methylbutanoate, its optical, positional, and geometric isomers, salts and salts of isomers MMB-CHMICA, AMB-CHMICA C-I 7/12/2018 Board Order
44-53-190(D)
1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers 5F-CUMYL-P7AICA C-I 7/12/2018 Board Order
44-53-190(D)
Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers. (a) Fentanyl-related substance means any substance that is structurally related to fentanyl by one or more of the following modifications: 1. Replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle; 2. Substitution in or on the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro groups; 3. Substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino or nitro groups; 4. Replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; and/or 5. Replacement of the N-propionyl group by another acyl group.   C-I 2/8/2018 Board Order 44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide, its isomers, esters, ethers, salts and salts of isomers, esters and
ethers		 Valeryl Fentanyl C-I 2/8/2018 Board Order 44-53-190(B)
N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide, its isomers, esters, ethers, salts and salts of isomers, esters
and ethers		 Para-Fluorobutyryl Fentanyl C-I 2/8/2018 Board Order 44-53-190(B)
N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide, its isomers, esters, ethers, salts and salts of isomers,
esters and ethers		 Para-Methoxybutyryl Fentanyl C-I 2/8/2018 Board Order 44-53-190(B)
N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide, its isomers, esters, ethers, salts and salts of isomers,
esters and ethers		 Para-Chloroisobutyryl Fentanyl C-I 2/8/2018 Board Order 44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide, its isomers, esters, ethers, salts and salts of isomers, esters and
ethers		 Isobutyryl Fentanyl C-I 2/8/2018 Board Order 44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide, its isomers, esters, ethers, salts and salts of isomers,
esters and ethers		 Cyclopentyl Fentanyl C-I 2/8/2018 Board Order 44-53-190(B)
N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide, its isomers, esters, ethers, salts and salts of isomers,
esters and ethers		 Ocfentanil C-I 2/8/2018 Board Order 44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide(cyclopropyl fentanyl), its isomers, esters, ethers, salts and salts of isomers, esters and ethers Cyclopropyl Fentanyl C-I 1/30/2018 Board Order 44-53-190(B)
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) MT-45 C-I 1/4/2018 Board Order 44-53-190(B)
methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, its isomers, esters, ethers, salts and salts of isomers, esters and ethers FUB-AMB, MMB-FUBINACA, AMB-FUBINACA C-I 11/9/2017 Board Order 44-53-190(D)
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers Ortho-Fluorofentanyl, 2-Fluorofentanyl C-I 11/9/2017 Board Order 44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers Tetrahydrofuranyl Fentanyl C-I 11/9/2017 Board Order 44-53-190(B)
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers Methoxyacetyl Fentanyl C-I 11/9/2017 Board Order 44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers Acryl Fentanyl C-I 8/10/2017 Board Order 44-53-190(B)
4-Fluoroisobutyryl Fentanyl N-(4-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyryl fentanyl or parafluoroisobutyryl fentanyl) C-I 5/11/2017 Board Order 44-53-190(B)
Dronabinol [(-)-delta-9-trans tetrahydrocannabinol (delta-9-THC)] in an oral solution Syndros C-II 4/5/2017 Board Order 44-53-210 (Other)
N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide Furanyl Fentanyl C-I 12/8/2016 Board Order 44-53-190(B)
3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide U-47700, (9547), PINK C-I 11/10/2016 Board Order 44-53-190(B)
(4-(methoxycarbonyl)-4-(N-phenmethoxyacetamido)-1-[2-(thienyl)ethyl]piperidine) Thiafentanil C-II 9/8/2016 Board Order 44-53-210(c)
(4-(methoxycarbonyl)-4-(N-phenmethoxyacetamido)-1-[2-(thienyl)ethyl]piperidine) Thiafentanyl C-II 9/8/2016 Board Order 44-53-210(c)
((2S)-2-[4R)-2-oxo-4-propypyrrolidin-1-yl] butanamide)Brivaracetam BRV, UCB-34714, Briviact C-V 6/9/2016 Board Order 44-53-270(c)
3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide AH-7921 C-I 5/12/2016 Board Order 44-53-190(B)
N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide Butyryl Fentanyl C-I 5/12/2016 Board Order 44-53-190(B)
N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpriopionamide Beta-Hydroxythiofentanyl C-I 5/12/2016 Board Order 44-53-190(B)
Updated Definition of Substiuted Cathinones to include underlined portion: (4) Substituted Cathinones, Any compound (not being bupropion) structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways: (a) by substitution in the phenyl ring to any extent with alkyl, alkenyl, alkoxy, alkylendioxy, haloalkyl, or halide subsituents, whether or not further substituted in the phenyl ring by one or more univalent substituents; (b) by substitution at the 3-position with an alkyl substituent; (c) by substitution at the nitrogen atom with alkyl or dialkyl groups, benzyl, or methoxybenzyl groups; or (d) by inclusion of the nitrogen atom in a cyclic structure. Including but not limited to: Methylone, Mephedrone, MDPV, Butylone, Methedrone, 4-MEC, Flephedrone, Pentylone, Pentedrone, Buphedrone, alpha-PVP, 4-MePPP, 4-FMC, 3-FMC, alpha-PBP, naphyrone C-I 3/10/2016 Board Order 44-53-190(F)
5-[[[(2s)-2-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]2-methoxybenzoic acid Eluxadoline C-IV 12/10/2015 Board Order 44-53-250(e)
N-(1- phenethylpiperidin-4-yl)-N-phenylacetamide Acetyl Fentanyl C-I 6/11/2015 Board Order 44-53-190(B)
Syntehtic Cannabinoids: Indazole-3-carboxamides. Any compound containing an Indazole-3-carboxamide structure with substitution at the nitrogen atom of the indazole ring by alkyl, haloalkyl, halobenzyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring to any extent. Including, but not limited, to AKB-48, AB-FUBINACA, AB-PINACA, ADB-FUBINACA, ADB-PINACA. AKB-48, AB-FUBINACA, AB-PINACA, ADB-FUBINACA, ADB-PINACA, AB-CHMINACA, THJ-2201, 5-Fluoro-AMB C-I 12/11/2014 Board Order 44-53-190(D)
13-beta-ethyl-17beta-hydroxygon-4-en-3-one   C-III 12/8/2022 Board Order 44-53-230
17-alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane   C-III 12/8/2022

Board Order

 44-53-230
17-alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane   C-III 12/8/2022 Board Order 44-53-230
17-alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene   C-III 12/8/2022 Board Order 44-53-230
17-alpha-methyl-4-hydroxynandrolone   C-III 12/8/2022 Board Order 44-53-230
17-alpha-methyl-delta1-dihydrotestosterone   C-III 12/8/2022 Board Order 44-53-230
19-nor-4,9(10)-androstadienedione   C-III 12/8/2022 Board Order 44-53-230
19-nor-4-androstenediol   C-III 12/8/2022 Board Order 44-53-230
19-nor-4-androstenedione   C-III 12/8/2022 Board Order 44-53-230
19-nor-5-androstenediol   C-III 12/8/2022 Board Order 44-53-230
19-nor-5-androstenedione   C-III 12/8/2022 Board Order 44-53-230
1-androstenediol   C-III 12/8/2022 Board Order 44-53-230
1-androstenedione   C-III 12/8/2022 Board Order 44-53-230
3-alpha,17beta-dihydroxy-5alpha-androstane   C-III 12/8/2022 Board Order 44-53-230
3-beta,17beta-dihydroxy-5alpha-androstane   C-III 12/8/2022 Board Order 44-53-230
4-androstenediol   C-III 12/8/2022 Board Order 44-53-230
4-androstenedione   C-III 12/8/2022 Board Order 44-53-230
4-dihydrotestosterone   C-III 12/8/2022 Board Order 44-53-230
4-hydroxy-19-nortestosterone   C-III 12/8/2022 Board Order 44-53-230
4-hydroxytestosterone   C-III 12/8/2022 Board Order 44-53-230
5-androstenediol   C-III 12/8/2022 Board Order 44-53-230
5-androstenedione   C-III 12/8/2022 Board Order 44-53-230
androstanedione   C-III 12/8/2022 Board Order 44-53-230
bolasterone   C-III 12/8/2022 Board Order 44-53-230
boldenone   C-III 12/8/2022 Board Order 44-53-230
boldione   C-III 112/8/2022 Board Order 44-53-230
calusterone   C-III 12/8/2022 Board Order 44-53-230
delta1-dihydrotestosterone   C-III 12/8/2022 Board Order 44-53-230
desoxymethyltestosterone   C-III 12/8/2022 Board Order 44-53-230
drostanolone   C-III 12/8/2022 Board Order 44-53-230
formebolone   C-III 12/8/2022 Board Order 44-53-230
furazabol   C-III 12/8/2022 Board Order 44-53-230
mestanolone   C-III 12/8/2022 Board Order 44-53-230
methandriol   C-III 12/8/2022 Board Order 44-53-230
methyldienolone   C-III 12/8/2022 Board Order 44-53-230
methyltrienolone   C-III 12/8/2022 Board Order 44-53-230
mibolerone   C-III 12/8/2022 Board Order 44-53-230
norbolethone   C-III 12/8/2022 Board Order 44-53-230
norclostebol   C-III 12/8/2022 Board Order 44-53-230
normethandrolone   C-III 12/8/2022 Board Order 44-53-230
prostanozol   C-III 12/8/2022 Board Order 44-53-230
stenbolone   C-III 12/8/2022 Board Order 44-53-230
testolactone   C-III 12/8/2022 Board Order 44-53-230
tetrahydrogestrinone   C-III 12/8/2022 Board Order 44-53-230
trenbolone   C-III 12/11/2014 Board Order 44-53-230
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine 2C-E C-I 12/11/2014 Board Order 44-53-190(D)
2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine 2C-I C-I 12/11/2014 Board Order 44-53-190(D)
4-Bromo-2,5-dimethoxyphenethylamine 2C-B C-I 12/11/2014 Board Order 44-53-190(D)
1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine PEPAP C-I 12/11/2014 Board Order 44-53-190(B)
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine TCPy C-I 12/11/2014 Board Order 44-53-190(D)
1-Methyl-4-phenyl-4-propionoxypiperidine MPPP C-I 12/11/2014 Board Order 44-53-190(B)
2-(2,5-Dimethoxy-4-(n)-prophylphenyl) ethanamine 2C-P C-I 12/11/2014 Board Order 44-53-190(D)
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine 2C-D C-I 12/11/2014 Board Order 44-53-190(D)
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine 2C-N C-I 12/11/2014 Board Order 44-53-190(D)
2-(2,5-Dimethoxyphenyl) ethanamine 2C-H C-I 12/11/2014 Board Order 44-53-190(D)
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine 2C-C C-I 12/11/2014 Board Order 44-53-190(D)
2-(4-ethylthio-2,5-dimethoxyphenyl) ethanamine 2C-T-2 C-I 12/11/2014 Board Order 44-53-190(D)
2-(4-ethylthio-2,5-dimethoxyphenyl) ethanamine 2C-T-4 C-I 12/11/2014 Board Order 44-53-190(D)
2,5-Dimethoxy-4-(n)propylthiophenethylamine 2C-T-7 C-I 12/11/2014 Board Order 44-53-190(D)
2,5-Dimethoxy-4-ethylamphetamine DOE, DOET, Hecate C-I 12/11/2014 Board Order 44-53-190(D)
3,4-Methylenedioxy-N-ethylamphetamine MDEA C-I 12/11/2014 Board Order 44-53-190(D)
3-Methoxy-4,5-methylenedioxyamphetamine MMDA C-I 12/11/2014 Board Order 44-53-190(D)
3-Methylfentanyl   C-I 12/11/2014 Board Order 44-53-190(B)
3-Methylthiofentanyl   C-I 12/11/2014 Board Order 44-53-190(B)
4-Methylaminorex (cis isomer)   C-I 12/11/2014 Board Order 44-53-190(F)
5 Methoxy-N,N,Dimethyltryptamine 5-MeO-DMT C-I 12/11/2014 Board Order 44-53-190(D)
5-Iodo-2-aminoindane 5-IAI C-I 12/11/2014 Board Order 44-53-190(D)
5-Methoxy-N,N-diisopropyltryptamine 5-MeO-DIPT C-I 12/11/2014 Board Order 44-53-190(D)
Acetyl-alpha-methylfentanyl   C-I 12/11/2014 Board Order 44-53-190(B)
Alpha-ethyltryptamine alpha-ET C-I 12/11/2014 Board Order 44-53-190(D)
Alpha-methylthiofentanyl   C-I 12/11/2014 Board Order 44-53-190(B)
Alpha-methyltryptamine AMT C-I 12/11/2014 Board Order 44-53-190(D)
Aminorex   C-I 12/11/2014 Board Order 44-53-190(F)
Beta-hydroxy-3-methylfentanyl   C-I 12/11/2014 Board Order 44-53-190(B)
Beta-hydroxyfentanyl   C-I 12/11/2014 Board Order 44-53-190(B)
Cyclohexamine Ethylamine analog of phencyclidine, PCE C-I 12/11/2014 Board Order 44-53-190(D)
N,N-Dimethylamphetamine Metrotonin C-I 12/11/2014 Board Order 44-53-190(F)
N-Benzylpiperazine BZP C-I 12/11/2014 Board Order 44-53-190(F)
Para-Fluorofentanyl   C-I 12/11/2014 Board Order 44-53-190(B)
Rolicyclidine Pyrrolidine analog of phencyclidine, PHP, PCPy C-I 12/11/2014 Board Order 44-53-190(D)
Synthetic Cannabinoid: Indole -3-carboxamides. Any compound containing an Indole-3-carboxamide structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring to any extent. Including, but not limited, to STS-135. STS-135 C-I 12/11/2014 Board Order 44-53-190(D)
Synthetic Cannabinoid: Indazole-3-carboxamides. Any compound containing an Indazole-3-carboxamide structure with substitution at the nitrogen atom of the indazole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring to any extent. Including, but not limited, to AKB-48, AB-FUBINACA, AB-PINACA, ADB-FUBINACA, ADB-PINACA. AKB-48, AB-FUBINACA, AB-PINACA, ADB-FUBINACA, ADB-PINACA, AB-CHMINACA, THJ-2201, 5-Fluoro-AMB C-I 12/11/2014 Board Order 44-53-190(D)
Synthetic Cannabinoid: N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecanamide CB-52 C-I 12/11/2014 Board Order 44-53-190(D)
Synthetic Cannabinoid: N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecanamide CB-25 C-I 12/11/2014 Board Order 44-53-190(D)
Synthetic Cannabinoid: N-cyclopropyl-8-[3-(1,1-dimethylheptyl)-5-hydroxyphenoxy]-octanamide CB-86 C-I 12/11/2014 Board Order 44-53-190(D)
Synthetic Cannabinoid: (6aR,9R,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydrobenzo [c]chromene-1,9-diol HU-243, Canbisol C-I 12/11/2014 Board Order 44-53-190(D)
Synthetic Cannabinoid: [(6S,6aR, 9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate Levantradol, CP 50,556-1 C-I 12/11/2014 Board Order 44-53-190(D)
Synthetic Cannabinoid: 1-napthalenyl[4-(pentylox)-1-napthalenyl]-methanone CB-13, CRA-13 C-I 12/11/2014 Board Order 44-53-190(D)
Synthetic Cannabinoid: 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione HU-331 C-I 12/11/2014 Board Order 44-53-190(D)
Synthetic Cannabinoid: 4-[4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl]-6,6-dimethyl-bicyclo[3.1.1] hept-2-ene-2-methanol HU-308 C-I 12/11/2014 Board Order 44-53-190(D)
Synthetic Cannabinoids: Quinolinyl-Indole Carboxylates. Any compound containing a quinolinyl-indole-3-carboxylate structure with substitution of the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring or quinolinyl structure to any extent. Including but not limited to PB-22, 5-F-PB-22. PB-22; 5-F-PB-22; BB-22 C-I 12/11/2014 Board Order 44-53-190(D)
Synthetic Cannaninoid: Indole - 3-ylcycloalkyl ketones. Any compound containing an Indole-3-ylcycloalkyl ketone structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent or whether or not substituted at the cycloalkyl ring to any extent. Including, but not limited to, XLR-11, UR-144, A-834735, A-796260, AB-001, AB-005 XLR-11, UR-144, A-834735, A-796260, AB-001, AB-005, 5-bromo-UR-144, 5-chloro-UR-144, 5-fluoro-144, AB-034 C-I 12/11/2014 Board Order 44-53-190(D)
Tenocyclidine 1-[1-(2-Thienyl)cyclohexyl]piperidine, TCP C-I 12/11/2014 Board Order 44-53-190(D)
Thiofentanyl   C-I 12/11/2014 Board Order 44-53-190(B)
4-Anilino-N-phenethyl-4-piperidine ANPP C-II 12/11/2014 Board Order 44-53-210(c)
Alfentanil   C-II 12/11/2014 Board Order 44-53-210(c)
Dihydroetorphine   C-II 12/11/2014 Board Order 44-53-210(c)
Diprenorphine   C-II 12/11/2014 Board Order 44-53-210(c)
Levo-alphacetylmethadol LAAM C-II 12/11/2014 Board Order 44-53-210(c)
Lisdexamfetamine   C-II 12/11/2014 Board Order 44-53-210(d)
Nabilone   C-II 12/11/2014 Board Order 44-53-210(h)
Oripavine   C-II 12/11/2014 Board Order 44-53-210(c)
Oxycodone   C-II 12/11/2014 Board Order 44-53-210(c)
Remifentanil   C-II 12/11/2014 Board Order 44-53-210(c)
Tapentadol   C-II 12/11/2014 Board Order 44-53-210(c)
Thebaine   C-II 12/11/2014 Board Order 44-53-210(c)
Buprenorphine   C-III 12/11/2014 Board Order 44-53-230(e)
Dronabinol in sesame oil and encapsulated in a soft gelatin capsule marinol - synthetic delta 9 tetrahydrocannabinol (THC) C-III 12/11/2014 Board Order 44-53-230(e)
Embutramide   C-III 12/11/2014 Board Order 44-53-230(c)
Ketamine   C-III 12/11/2014 Board Order 44-53-230(c)
Sulfonmethane   C-III 12/11/2014 Board Order 44-53-230(c)
Tiletamine & Zolazepam Combination Product   C-III 12/11/2014 Board Order 44-53-230(c)
Cathine   C-IV 12/11/2014 Board Order 44-53-250(b)
Dichloralphenazone   C-IV 12/11/2014 Board Order 44-53-250(a)
Fencamfamin   C-IV 12/11/2014 Board Order 44-53-250(b)
Fenproporex   C-IV 12/11/2014 Board Order 44-53-250(b)
Fospropofol   C-IV 12/11/2014 Board Order 44-53-250(a)
Mefenorex   C-IV 12/11/2014 Board Order 44-53-250(b)
Midazolam   C-IV 12/11/2014 Board Order 44-53-250(a)
Modafinil   C-IV 12/11/2014 Board Order 44-53-250(b)
Phenazepam   C-IV 12/11/2014 Board Order 44-53-250(a)
Pyrazolam   C-IV 12/11/2014 Board Order 44-53-250(a)
Quazepam   C-IV 12/11/2014 Board Order 44-53-250(a)
Sibutramine   C-IV 12/11/2014 Board Order 44-53-250(b)
Zaleplon   C-IV 12/11/2014 Board Order 44-53-250(a)
Zolpidem   C-IV 12/11/2014 Board Order 44-53-250(a)
Zopiclone   C-IV 12/11/2014 Board Order 44-53-250(a)
Lacosamide   C-V 12/11/2014 Board Order 44-53-270(c)
Pregabalin   C-V 12/11/2014 Board Order 44-53-270(c)
Pyrovalerone   C-V 12/11/2014 Board Order 44-53-270(d)
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl}{5=methyl-2-(2H-123-triazol-2-yl)phenyl]methanone Suvorexant C-IV 9/25/2014 Board Order 44-53-250(a)
Dihydrocodeine - Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts.   C-II 9/11/2014 Board Order 44-53-230(e)
Dihydrocodeine - Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a four-fold or greater quantity of an isoquinoline alkaloid of opium.   C-II 9/11/2014 Board Order 44-53-230(e)
Dihydrocodeine - Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts.   C-II 9/11/2014 Board Order 44-53-230(e)
Hydrocodone Combination Products Lortab C-II 9/11/2014 Board Order 44-53-210(c)
2-[(dimethylamino)methyl]-1-(3-Methoxyphenyl)cyclohexanol Tramadol C-IV 7/10/2014 Board Order 44-53-250(e)
Alfaxalone Alfaxalone C-IV 3/13/2014 Board Order 44-53-250(a)
Synthetic Cannabinoid: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide ADB-PINACA C-I 2/27/2014 Board Order 44-53-190(D)
Synthetic Cannabinoid: N-(1-amino-3-methyl-1-oxobutan-2-yl-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide AB-FUBINACA C-I 2/27/2014 Board Order 44-53-190(D)
Synthetic Cannabinoid: Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3 carboxylate 5-fluoro-PB-22; 5F-PB-22 C-I 2/27/2014 Board Order 44-53-190(D)
Synthetic Cannabinoid: Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate PB-22; QUPIC C-I 2/27/2014 Board Order 44-53-190(D)
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36 C-I 12/12/2013 Board Order 44-53-190(D)
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82 C-I 12/12/2013 Board Order 44-53-190(D)
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine 25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5 C-I 12/12/2013 Board Order 44-53-190(D)
Lorcaserin Lorcaserin C-IV 6/4/2013 Board Order 44-53-250(c)
Synthetic Cannabinoid: 1-(5-fluoro-pentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone 5-fluoro-UR-144; XLR-11; XLRl 1 C-I 5/9/2013 Board Order 44-53-190(D)
Synthetic Cannabinoid: 1-pentyl-1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl) methanone UR-144 C-I 5/9/2013 Board Order 44-53-190(D)
Synthetic Cannabinoid: N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide APINACA, AKB48 C-I 5/9/2013 Board Order 44-53-190(D)
Carisoprodol Soma C-IV 2/9/2012 Board Order 44-53-250(a)
Carisoprodol+Aspirin SOMA Compound C-IV 2/9/2012 Board Order 44-53-250(a)
3,4-methylenedioxy-N-methylcathinone Methylone C-I 10/24/2011 Board Order 44-53-190(F)
3,4-methylenedioxypyrovalerone MDPV C-I 10/24/2011 Board Order 44-53-190(F)
4-methyl-N-methylcathinone Mephedrone C-I 10/24/2011 Board Order 44-53-190(F)
Synthetic Cannabinoid: 1-Butyl-3-(1-napthoyl)indole JWH-073 C-I 10/24/2011 Board Order 44-53-190(D)
Synthetic Cannabinoid: 1-Pentyl-3-(1-napthoyl)indole JWH-018; AM678 C-I 10/24/2011 Board Order 44-53-190(D)
Synthetic Cannabinoid: 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol CP-47,497 C-I 10/24/2011 Board Order 44-53-190(D)
Synthetic Cannabinoid: 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol cannabicyclohexanol; CP-47,497 C8 homologue C-I 10/24/2011 Board Order 44-53-190(D)
Synthetic Cannabinoid: 1-[2-(4-Morpholinyl)ethyl]-3-(1-napthoyl)indole JWH-200 C-I 10/24/2011 Board Order 44-53-190(D)
Ethylestrenol   C-III 12/8/2022 Board Order 44-53-230
Fluoxymesterone   C-III 12/8/2022 Board Order 44-53-230
Mesterolone   C-III 12/8/2022 Board Order 44-53-230
Methandienone   C-III 12/8/2022 Board Order 44-53-230
Methandrostenolone   C-III 12/8/2022 Board Order 44-53-230
Methenolone   C-III 12/8/2022 Board Order 44-53-230
Methyltestosterone   C-III 12/8/2022 Board Order 44-53-230
Nandrolone   C-III 12/8/2022 Board Order 44-53-230
Norethandrolone   C-III 12/8/2022 Board Order 44-53-230
Oxandrolone   C-III 12/8/2022 Board Order 44-53-230
Oxymesterone   C-III 12/8/2022 Board Order 44-53-230
Oxymetholone   C-III 12/8/2022 Board Order 44-53-230
Stanozolol   C-III 12/8/2022 Board Order 44-53-230
Testosterone   C-III 12/8/2022 Board Order 44-53-230
2,5-dimethoxyamphetamine   C-I     44-53-190(D)
3,4,5-trimethoxy amphetamine   C-I     44-53-190(D)
3,4-methylenedioxy amphetamine   C-I     44-53-190(D)
3,4-methylenedioxymethamphetamine (MDMA)   C-I     44-53-190(D)
4-bromo-2,5-dimethoxyamphetamine   C-I     44-53-190(D)
4-Methoxyamphetamine   C-I     44-53-190(D)
4-methyl-2,5-dimethoxyamphetamine (STP)   C-I     44-53-190(D)
5-methoxy-3,4-methylenedioxy amphetamine   C-I     44-53-190(D)
Acetorphine   C-I     44-53-190(C)
Acetyldihydrocodeine   C-I     44-53-190(C)
Acetylmethadol   C-I     44-53-190(B)
Alfentanyl   C-I     44-53-190(B)
Allylprodine   C-I     44-53-190(B)
Alphacetylmethadol   C-I     44-53-190(B)
Alphameprodine   C-I     44-53-190(B)
Alphamethadol   C-I     44-53-190(B)
Alphamethylfentanyl (N-[1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl-4-(N-pro-panilido) piperidine)   C-I     44-53-190(B)
Any compound (not being bupropion) structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways: (a) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more univalent substituents; (b) by substitution at the 3-position with an alkyl substituent; (c) by substitution at the nitrogen atom with alkyl or dialkyl groups, benzyl or methoxybenzyl groups; or (d) by inclusion of the nitrogen atom in a cyclic structure Including, but not limited to: Methylone, Mephedrone, 3,4-Methylenedioxypyrovalerone (MDPV), Butylone, Methedrone, 4-Methylethcathinone, Flephedrone, Pentylone, Pentedrone, Buphedrone C-I     44-53-190(F)
Benzethidine   C-I     44-53-190(B)
Benzylmorphine   C-I     44-53-190(C)
Betacetylmethadol   C-I     44-53-190(B)
Betameprodine   C-I     44-53-190(B)
Betamethadol   C-I     44-53-190(B)
Betaprodine   C-I     44-53-190(B)
Bufotenine   C-I     44-53-190(D)
Cathinone   C-I     44-53-190(F)
Clonitazene   C-I     44-53-190(B)
Codeine methylbromide   C-I     44-53-190(C)
Codeine-N-Oxide   C-I     44-53-190(C)
Cyprenorphine   C-I     44-53-190(C)
Desomorphine   C-I     44-53-190(C)
Dextromoramide   C-I     44-53-190(B)
Diampromide   C-I     44-53-190(B)
Diethylthiambutene   C-I     44-53-190(B)
Diethyltryptamine (DET)   C-I     44-53-190(D)
Difenoxin   C-I     44-53-190(B)
Dihydromorphine   C-I     44-53-190(C)
Dimenoxadol   C-I     44-53-190(B)
Dimepheptanol   C-I     44-53-190(B)
Dimethylthiambutene   C-I     44-53-190(B)
Dimethyltryptamine (DMT)   C-I     44-53-190(D)
Dioxaphetyl butyrate   C-I     44-53-190(B)
Dipipanone   C-I     44-53-190(B)
Drotebanol   C-I     44-53-190(C)
Ethylmethylthiambutene   C-I     44-53-190(B)
Etonitazene   C-I     44-53-190(B)
Etorphine   C-I     44-53-190(C)
Etoxeridine   C-I     44-53-190(B)
Fenethylline   C-I     44-53-190(F)
Furethidine   C-I     44-53-190(B)
Gamma Hydroxybutyric Acid   C-I     44-53-190(E)
Heroin   C-I     44-53-190(C)
Hydromorphinol   C-I     44-53-190(C)
Hydroxypethidine   C-I     44-53-190(B)
Ibogaine   C-I     44-53-190(D)
Ketobemidone   C-I     44-53-190(B)
Levomoramide   C-I     44-53-190(B)
Levophenacylmorphan   C-I     44-53-190(B)
Lysergic acid diethylamide (LSD)   C-I     44-53-190(D)
Marijuana   C-I     44-53-190(D)
Mecloqualone   C-I     44-53-190(E)
Mescaline   C-I     44-53-190(D)
Methaqualone   C-I     44-53-190(E)
Methyldesorphine   C-I     44-53-190(C)
Methylhydromorphine   C-I     44-53-190(C)
Morpheridine   C-I     44-53-190(B)
Morphine methylbromide   C-I     44-53-190(C)
Morphine methylsulfonate   C-I     44-53-190(C)
Morphine-N-Oxide   C-I     44-53-190(C)
Myrophine   C-I     44-53-190(C)
N-ethyl-3-piperidyl benzilate   C-I     44-53-190(D)
N-ethylamphetamine   C-I     44-53-190(F)
Nicocodeine   C-I     44-53-190(C)
Nicomorphine   C-I     44-53-190(C)
N-methyl-3-piperidyl benzilate   C-I     44-53-190(D)
Noracymethadol   C-I     44-53-190(B)
Norlevorphanol   C-I     44-53-190(B)
Normethadone   C-I     44-53-190(B)
Normorphine   C-I     44-53-190(C)
Norpipanone   C-I     44-53-190(B)
Parahexyl   C-I     44-53-190(D)
Peyote   C-I     44-53-190(D)
Phenadoxone   C-I     44-53-190(B)
Phenampromide   C-I     44-53-190(B)
Phenomorphan   C-I     44-53-190(B)
Phenoperidine   C-I     44-53-190(B)
Pholcodine   C-I     44-53-190(C)
Piritramide   C-I     44-53-190(B)
Proheptazine   C-I     44-53-190(B)
Properidine   C-I     44-53-190(B)
Propiram   C-I     44-53-190(B)
Psilocybin   C-I     44-53-190(D)
Psilocyn   C-I     44-53-190(D)
Racemoramide   C-I     44-53-190(B)
Substituted Cathinones   C-I     44-53-190(F)
Synthetic Cannabinoid 24 (d.) Naphthylmethylindenes. Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent   C-I     44-53-190(D)
Synthetic Cannabinoid 24 (e.) Phenylacetylindoles. Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, SR-18, RCS-8, JWH-203, JWH-250, JWH-251, JWH-302 C-I     44-53-190(D)
Synthetic Cannabinoid 24 (f.) Cyclohexylphenols. Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to, CP 47,497 (and homologues), cannabicyclohexanol, CP-55, 940. C-I     44-53-190(D)
Synthetic Cannabinoid 24 (h.) 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de]-1, 4-benzoxazin-6-yl]-1-napthalenylmethanone (WIN 55,212-2) WIN 55,212-2 C-I     44-53-190(D)
Synthetic Cannabinoid 24 (i.) 9-(hydroxymethyl)-6,6-dimethy l-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol 7370 (HU-210, HU-211) HU-210, HU-211 C-I     44-53-190(D)
Synthetic Cannabinoid 24 (j.) Adamantoylindoles. Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring system to any extent Including but not limited to: AB-001, AB-002, AM1248 C-I     44-53-190(D)
Synthetic Cannabinoid 24(g.) Benzoylindoles. Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, AM-694, Pravadoline (WIN 48,098), RCS-4, AM-630, AM-1241, AM-2233 C-I     44-53-190(D)
Synthetic Cannabinoid 24. (a.) Naphthoylindoles. Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-398, AM-2201, WIN 55-212, AM-2201 (C1 analog), AM-1220 C-I     44-53-190(D)
Synthetic cannabinoid 24. (b.) Naphthylmethylindoles. Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent Including but not limited to: JWH-175, JWH-184 C-I     44-53-190(D)
Synthetic Cannabinoid 24. (c.) Naphthoylpyrroles. Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-307, JWH-370, JWH-176 C-I     44-53-190(D)
Synthetic cannabinoids.--24. Any material, compound, mixture, or preparation that is not listed as a controlled substance in Schedule I through V, is not an FDA-approved drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues, and salts of isomers and homologues, unless specifically excepted, whenever the existence of these salts, isomers, homologues, and salts of isomers and homologues is possible within the specific chemical designation.   C-I     44-53-190(D)
Tetrahydrocannabinol (THC)   C-I     44-53-190(D)
Thebacon   C-I     44-53-190(C)
Thiophene analog of phencyclidine   C-I     44-53-190(D)
Tilidine   C-I     44-53-190(B)
Trimeperidine   C-I     44-53-190(B)
Alphaprodine   C-II     44-53-210(c)
Amobarbital   C-II     44-53-210(f)
Amphetamine, its salts, optical isomers, and salts of its optical isomers   C-II     44-53-210(d)
Anileridine   C-II     44-53-210(c)
Any salt, compound, isomer, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (1), but not including the isoquinoline alkaloids of opium   C-II     44-53-210(b)
Bezitramide   C-II     44-53-210(c)
Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions which do not contain cocaine or ecgonine   C-II     44-53-210(b)
Dextropropoxyphene [alpha-(+" )-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane], in bulk form   C-II     44-53-210(c)
Dihydrocodeine   C-II     44-53-210(c)
Diphenoxylate   C-II     44-53-210(c)
Fentanyl   C-II     44-53-210(c)
Isomethadone   C-II     44-53-210(c)
Levomethorphan   C-II     44-53-210(c)
Levorphanol   C-II     44-53-210(c)
Metazocine   C-II     44-53-210(c)
Methadone   C-II     44-53-210(c)
Methadone - Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane   C-II     44-53-210(c)
Methamphetamine, its salts, and salts of isomers   C-II     44-53-210(d)
Methylphenidate   C-II     44-53-210(d)
Moramide - Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid   C-II     44-53-210(c)
Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding Apomorphine, Nalbuphine, Naloxone, and Naltrexone, and their respective salts   C-II     44-53-210(b)
Opium poppy and poppy straw   C-II     44-53-210(b)
Pentazocine (to be administered by injection only)   C-II     44-53-210(c)
Pentobarbital   C-II     44-53-210(f)
Pethidine - Intermediate-A, 4-cyano-1-methyl-4-phenyl-piperidine   C-II     44-53-210(c)
Pethidine - Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate   C-II     44-53-210(c)
Pethidine - Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid   C-II     44-53-210(c)
Pethidine (meperidine)   C-II     44-53-210(c)
Phenazocine   C-II     44-53-210(c)
Phencyclidine immediate precursors: (a) 1-phenylcyclohexylamine; (b) 1-piperidinocyclohexanecarbonitrile (PCC); (g) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substance: (1) Immediate precursor to amphetamine and methamphetamine: (i) Phenylacetone, also known as phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone.   C-II     44-53-210(f)
Phencyclidine   C-II     44-53-210(f)
Phenmetrazine and its salts   C-II     44-53-210(d)
Phenylacetone (Immediate precurser to amphetamine or methamphetamine) phenyl-2-propanone, P2P, benzyl methyl ketone, methyl benzyl ketone C-II     44-53-210(g)
Piminodine   C-II     44-53-210(c)
Racemethorphan   C-II     44-53-210(c)
Racemorphan   C-II     44-53-210(c)
Secobarbital   C-II     44-53-210(f)
Sufentanil   C-II     44-53-210(c)
any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital or any salt thereof and one or more other active ingredients which are not listed in any schedule   C-III     44-53-230(c)
any substance which contains any quantity of a derivative or barbituric acid or any salt thereof;   C-III     44-53-230(c)
any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the United States Food and Drug Administration for marketing only as a suppository;   C-III     44-53-230(c)
Benzphetamine   C-III     44-53-230(b)
Chlorhexadol   C-III     44-53-230(c)
Chlorphentermine   C-III     44-53-230(b)
Clortermine   C-III     44-53-230(b)
Gamma Hydroxybutyric Acid, and its salts, isomers, and salts of isomers contained in a drug product for which an application has been approved under Section 505 of the Federal Food, Drug and Cosmetic Act   C-III     44-53-230(c)
Glutehimide   C-III     44-53-230(c)
Lysergic Acid   C-III     44-53-230(c)
Lysergic Acid Amide   C-III     44-53-230(c)
Methyprylon   C-III     44-53-230(c)
Nalorphene   C-III     44-53-230(d)
Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium.   C-III     44-53-230(e)
Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts   C-III     44-53-230(e)
Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts.   C-III     44-53-230(e)
Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one or more active, non-narcotic ingredients in recognized therapeutic amounts.   C-III     44-53-230(e)
Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts.   C-III     44-53-230(e)
Phendimetrazine   C-III     44-53-230(b)
Sulfondiethylmethane   C-III     44-53-230(c)
Sulfonethylmethane   C-III     44-53-230(c)
Sulfonmethane   C-III     44-53-230(c)
Alprazolam   C-IV     44-53-250(a)
Barbital   C-IV     44-53-250(a)
Bromazepam   C-IV     44-53-250(a)
Butorphanol   C-IV     44-53-250(g)
Camazepam   C-IV     44-53-250(a)
Chloral Betaine   C-IV     44-53-250(a)
Chloral Hydrate   C-IV     44-53-250(a)
Chlordiazepoxide   C-IV     44-53-250(a)
Clobazam   C-IV     44-53-250(a)
Clonazepam   C-IV     44-53-250(a)
Clorazepate   C-IV     44-53-250(a)
Clotiazepam   C-IV     44-53-250(a)
Cloxazolam   C-IV     44-53-250(a)
Delorazepam   C-IV     44-53-250(a)
Diazepam   C-IV     44-53-250(a)
Diethylpropion   C-IV     44-53-250(b)
Dosage forms of Dextropropoxyphene [Alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane]   C-IV     44-53-250(e)
Estazolam   C-IV     44-53-250(a)
Ethchlorvynol   C-IV     44-53-250(a)
Ethinamate   C-IV     44-53-250(a)
Ethyl Loflazepate   C-IV     44-53-250(a)
Fludiazepam   C-IV     44-53-250(a)
Flunitrazepam   C-IV     44-53-250(a)
Flurazepam   C-IV     44-53-250(a)
Halazepam   C-IV     44-53-250(a)
Haloxazolam   C-IV     44-53-250(a)
Ketazolam   C-IV     44-53-250(a)
Loprazolam   C-IV     44-53-250(a)
Lorazepam   C-IV     44-53-250(a)
Lormetazepam   C-IV     44-53-250(a)
Mazindol   C-IV     44-53-250(b)
Mebutamate   C-IV     44-53-250(a)
Medazepam   C-IV     44-53-250(a)
Meprobamate   C-IV     44-53-250(a)
Methohexital   C-IV     44-53-250(a)
Methylphenobarbital   C-IV     44-53-250(a)
Nimetazepam   C-IV     44-53-250(a)
Nitrazepam   C-IV     44-53-250(a)
Nordiazepam   C-IV     44-53-250(a)
Not more than one milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit.   C-IV     44-53-250(e)
Oxazepam   C-IV     44-53-250(a)
Oxazolam   C-IV     44-53-250(a)
Paraldehyde   C-IV     44-53-250(a)
Pemoline, including organometallic complexes and chelates thereof   C-IV     44-53-250(b)
Pentazocine hydrochloride and acetaminophen, pentazocine hydrochloride and aspirin, and pentazocine and naloxone hydrochloride (all for oral administration only).   C-IV     44-53-250(f)
Petrichloral   C-IV     44-53-250(a)
Phenobarbital   C-IV     44-53-250(a)
Phentermine   C-IV     44-53-250(b)
Pinazepam   C-IV     44-53-250(a)
Pipradol   C-IV     44-53-250(b)
Prazepam   C-IV     44-53-250(a)
SPA [(-)-1-Dimethylamino-1, 2-diphenylethane]   C-IV     44-53-250(b)
Temazepam   C-IV     44-53-250(a)
Tetrazepam   C-IV     44-53-250(a)
Triazolam   C-IV     44-53-250(a)
Not more than 200 milligrams of codeine per 100 milliliter or per 100 grams   C-V     44-53-250(b)
Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;   C-V     44-53-250(b)
Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;   C-V     44-53-250(b)
Not more than 100 milligrams of opium per 100 milliliters or per 100 grams   C-V     44-53-250(b)
Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit;   C-V     44-53-250(b)
Not more than one-half milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit.   C-V     44-53-250(b)